View in EDS

Adjusted comparison of daratumumab monotherapy versus real-world historical control data from the Czech Republic in heavily pretreated and highly refractory multiple myeloma patients.

Saved in:

Bibliographic Details
Title:	Adjusted comparison of daratumumab monotherapy versus real-world historical control data from the Czech Republic in heavily pretreated and highly refractory multiple myeloma patients.
Authors:	Jelínek, Tomáš¹, Maisnar, Vladimír², Pour, Luděk³, Špička, Ivan⁴, Minařík, Jiří⁵, Gregora, Evžen⁶, Kessler, Petr⁷, Sýkora, Michal⁸, Fraňková, Hana⁹, Adamová, Dagmar¹⁰, Wróbel, Marek¹¹, Mikula, Peter¹², Jarkovský, Jiří¹³, Diels, Joris¹⁴, Gatopoulou, Xenia¹⁵, Veselá, Šárka¹⁶, Besson, Hervé¹⁴, Brožová, Lucie¹³, Ito, Tetsuro¹⁷, Hájek, Roman¹⁸ roman.hajek@fno.cz
Source:	Current Medical Research & Opinion. May2018, Vol. 34 Issue 5, p775-783. 9p.
Database:	Academic Search Ultimate

Description
ISSN:	03007995
DOI:	10.1080/03007995.2017.1410121